141 filings
8-K
RNAC
Cartesian Therapeutics Inc
22 Apr 24
Other Events
6:25am
8-K
RNAC
Cartesian Therapeutics Inc
9 Apr 24
Regulation FD Disclosure
7:00am
8-K
RNAC
Cartesian Therapeutics Inc
1 Apr 24
Departure of Directors or Certain Officers
4:32pm
8-K
RNAC
Cartesian Therapeutics Inc
28 Mar 24
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
5:00pm
8-K
RNAC
Cartesian Therapeutics Inc
14 Mar 24
Termination of a Material Definitive Agreement
7:55am
8-K
q0u i3qc79vxcilifk4
7 Mar 24
Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
7:06am
8-K
8b9xviv8abkcr218c64a
5 Mar 24
Entry into a Material Definitive Agreement
7:05am
8-K/A
vjvi0
23 Jan 24
Independent Auditor’s Report
4:05pm
8-K
qma 2nakzgdk3mkg2
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:12pm
8-K
8qtx gy35
8 Jan 24
Regulation FD Disclosure
8:45am
8-K
z0dzl7e0qq kj
27 Nov 23
Departure of Directors or Certain Officers
4:18pm
8-K
5fdeqfa4n
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
8-K
1f1opz2f1 jtcwuyjhn
31 Oct 23
Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
4:06pm
8-K
fasb9zpa3ucafbs 7pu
25 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
ky0tuf b5w6
13 Sep 23
Other Events
7:33am
8-K
3k5mmki3 af7eij3zo
17 Aug 23
Results of Operations and Financial Condition
7:10am
8-K
xzpue5k
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:20pm
8-K
mfbps1
4 Apr 23
Entry into a Material Definitive Agreement
4:16pm
8-K
k8jzle gp6
21 Mar 23
Regulation FD Disclosure
8:30am
8-K
axzzj7jp
9 Jan 23
Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease
8:05am